Loading...
Loading...
is up less than one percent in after hours trading after the company reported its fourth quarter results.
The company reported a Q4 EPS of $(0.20), which is considerably lower than the Street estimate of $(0.05).
Earnings per share were down 137 percent from the year-ago period.
Revenue came in at $1.71 billion versus the Street estimate of $1.8 billion. Sales were up eight percent year-over-year.
Molina's CEO, J. Mario Molina, M.D.,
referred to 2013 as a year of both opportunity and challenge. He said that he believes the company has laid the foundation for success in 2014 and beyond by:
- Increasing medical margins.
- Securing Duals Demonstration contracts in five states.
- Expanding its footprint into South Carolina.
- Building the "robust" administrative infrastructure that the company will need going forward.
Year-to-date, Molina Healthcare has remained flat, losing a mere 0.06 percent as of market close on Friday, February 7. The stock has risen more than 17 percent over the last 12 months.
Disclosure:
At the time of this writing, Louis Bedigian had no position in the equities mentioned in this report.© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in